TRAWNasdaq United States
Market cap
$8.101 M
$0.53 -1.30%
Close of 7 Aug 2026
Revenue
$2.79M
#3400 by revenue
Earnings
$9.17M
#2067 by earnings
Shares outstanding
10,157,257
Latest filing cover page
P/E ratio
0.9
Cap ÷ net income
Where these numbers come from
Share counts and financials for Traws Pharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.